Subconjunctival Bevacizumab for Primary Pterygium Excision; a Randomized Clinical Trial
Purpose: To evaluate the safety of local bevacizumab and its effect on recurrence of primary pterygium excision. Methods: This randomized, placebo-controlled clinical trial was conducted on 44 eyes of 44 patients randomized to Group 1 (bevacizumab) and Group 2 (balanced salt solution). Group 1 unde...
Main Authors: | Mohammad-Reza Razeghinejad, Mohammad Banifatemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2014-01-01
|
Series: | Journal of Ophthalmic & Vision Research |
Subjects: | |
Online Access: | http://www.jovr.org/article.asp?issn=2008-322X;year=2014;volume=9;issue=1;spage=22;epage=30;aulast=Razeghinejad |
Similar Items
-
Subconjunctival Bevacizumab Injection in Treatment of Pterygium
by: Mohammad Reza Besharati, et al.
Published: (2011-03-01) -
Subconjunctival Bevacizumab Injection in Treatment of Pterygium
by: Mohammad Reza Besharati, et al.
Published: (2011-03-01) -
A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients
by: Priyanka Singh, et al.
Published: (2015-01-01) -
Subconjunctival bevacizumab injection versus mitomycin C application after primary pterygium surgery
by: Hani A Albialy, et al.
Published: (2019-01-01) -
Effect of single subconjunctival injection of bevacizumab on primary pterygium: clinical, histopathological and immunohistochemical study
by: Tarek A Mohamed, et al.
Published: (2018-05-01)